ESBLs are β-lactamases capable of conferring bacterial resistance to the penicillins, first, second, and third-generation cephalosporins, and aztreonam (but not the cephamycins or carbapenems) but these are inhibited by -lactamase inhibitors such as clavulanic acid. The ESBLs are typically plasmid-mediated enzymes, mostly produced by Gram negative bacteria. Extended spectrum beta lactamase (ESBLs) enzymes were first reported in Germany in 1983 from Klebsiella pneumonia. ESBL-producing Enterobacteriaceae have been responsible for numerous outbreaks of infection throughout the world and pose challenging infection control issues. Different phenotypic test for ESBL detection have been developed, which are easy to use and cost effective.
INTRODUCTION ESBL Detection Methods Screening Methods
CLSI has developed both disk diffusion and micro dilution screening tests using selected antimicrobial agents. Each Klebsiella pneumoniae, K. oxytoca, or Escherichia coli isolate should be considered a potential ESBL-producer if the test results are as follows:
Disk diffusion MICs
cefpodoxime < 22 mm cefpodoxime > 2 µg/ml Ceftazidime < 22 mm Ceftazidime > 2 µg/ml aztreonam < 27 mm Aztreonam > 2 µg/ml cefotaxime < 27 mm Cefotaxime > 2 µg/ml ceftriaxone < 25 mm ceftriaxone > 2 µg/ml
The sensitivity of screening for ESBLs in enteric organisms can vary depending on which antimicrobial agents are tested. The use of more than one of the five antimicrobial agents suggested for screening will improve the sensitivity of detection. Cefpodoxime and ceftazidime show the highest sensitivity for ESBL detection. minutes to pre-diffuse. An Augmentin which is a combination of clavulanic acid (20 μg) and amoxicillin (10 μg) was placed at the center of the plate and cefotaxime (30 μg), ceftaxidime (30 μg), aztreonam (30 μg) ciprofloxacin (30 μg) were placed 15 mm apart center to centre on the plates with a sterile forceps. These were incubated at 35oC for 18-24 h. An enhanced zone of inhibition from 5 mm above in the presence of Augmentin is regarded as positive for phenotypic production of ESBL enzyme.
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Three Dimensional test Two types of inocula are prepared. A disk diffusion test inoculum (0.5 McFarland standard) and a three dimensional inoculums (109 -1010 CFU/ml); in the direct threedimensional test, after the surface of the susceptibility plate was inoculated similar to conventional disk diffusion method as per CLSI guidelines, the agar was stabbed vertically with a sterile no. 11 scalpel blade so that the point of the blade passed to the bottom of the agar at a predetermined point 3 mm inside the position at which the antibiotic disks were to be placed. The three dimensional inoculum was dispensed into the slit so that the slit was filled but there was no overflow onto the agar surface. Conventional disk diffusion susceptibility test results are measured according to the recommendations of CLSI. Distortion or discontinuity in the circular inhibition zone is interpreted as positive for ESBL production. The advantage of this method is simultaneous determination of antibiotic susceptibility and β lactamase detection (but not specific for ESBLs). 
Interpretation
When the inhibition zone around the β lactam antibiotic is distorted in such a way that; the growth of the test organism appears within the zone behind the well and fully reaching the well so that; a heart shaped distortion of the inihibition zone around the Cefepime is seen. This is due to enzymatic inactivation of the test antibiotic by the β lactamase diffusing through the agar in the vicinity of the three dimensional test inoculums, resulting in gradually decreasing diameter of the inhibition zone towards the well.
Inhibitor potentiated disc diffusion test
This test is based on a modification of the standard discdiffusion method as described by the CLSI. Mueller-Hinton (MH) agar supplemented with 4 mg/L of clavulanate was prepared the day before testing with the addition of clavulanate after cooling to 50°C in a water bath. The inoculum was prepared by the direct colony suspension method to match the turbidity of a 0.5 McFarland standard. Antibiotic discs containing ceftazidime (30 g), cefotaxime (30 g), ceftriaxone (30 g) and aztreonam (30 g) were placed on 85 mm clavulanate-containing and clavulanate-free MH agar plates using a BBL Sensi-Disc dispenser. Up to three antibiotic discs were tested per agar plate. After overnight incubation at 37°C, the diameters of the inhibition zones around the antibiotic discs were measured. Augmentation zone widths were obtained by subtracting inhibition zone diameters produced by the lactam discs on clavulanate-free medium with those in clavulanate-containing medium. An augmentation zone width of 10 mm was considered positive for ESBL production. Each strain was tested on three separate occasions.
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ESBL E test Strip
This combines both the principles of dilution and diffusion techniques. E strip is a thin nonporous plastic strip 5 mm wide and 60 mm long. It carries two shorter gradients aligned in opposing directions on a single strip. One end generates a stable concentration gradient of one of the Oxyiminocephalosporins (e.g. Ceftazidime), while other end generates a gradient of Cephalosporin + Clavulanic acid (4 μg/ml). When the E strip is applied over a lawn culture Inhibition ellipse may be seen on the both ends of the strip. MIC is interpreted as the point of intersection of the inhibition ellipse with E test strip edge. This method is more sensitive and easy to use.
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CONCLUSION
Diagnostic laboratories demand cheaper and easy to use tests for detection of ESBL. These are more cost-effective and less labour intensive than genotypic methods of ESBL detection.
